Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus plantarum 299v and Improved Irritable Bowel Syndrome Symptoms

Research synthesisModerate evidenceLarge effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects of Lactobacillus plantarum 299v on irritable bowel syndrome symptoms, with effect sizes ranging from moderate to large; 1 study (a meta-analysis) found neutral results. The beneficial studies included a small randomized controlled trial (n=20) showing improvement in 95% of patients vs 15% with placebo (p<0.0001) and a larger observational study (n=221) showing significant symptom reduction. Effects are typically observed over 4–12 weeks, though median study duration was 28 days.

  • Effective dose range: 1×10^10 CFU/day
  • Studied populations: patients with IBS

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. The single meta-analysis (highest evidence score) did not demonstrate efficacy, which contradicts the smaller studies.

Generated Jun 17, 2026
Doses used in studies
  • CFU/day: 10 billion (median 10 billion, IQR 10 billion10 billion) 1 study
Time to effect
Median: 4 weeks · IQR 4 weeks4 weeks · Range 4 weeks4 weeks — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top